|By Marketwired .||
|February 18, 2014 05:00 AM EST||
SAN DIEGO, CA -- (Marketwired) -- 02/18/14 -- Ivera Medical Corporation, headquartered in San Diego, CA, announced that the United States District Court for the Southern District of California has denied a motion for summary judgment filed by Catheter Connections, Inc. in Ivera Medical's lawsuit alleging that Catheter Connections infringes U.S. Patent Nos. 7,780,794 ("the '794 patent"), 7,985,302 ("the '302 patent"), and 8,206,514 ("the '514 patent")(Consolidated Case Nos. 12-cv-954-H (RBB), 12-cv-1587-H (RBB)).
Ivera manufactures, markets, and sells the Curos® Disinfecting Port Protector, a pioneering device that disinfects and protects the entry port on certain types of valves used with intravenous lines. On August 24, 2010, the '794 patent, on an invention entitled "Medical Implement Cleaning Device," was issued by the United States Patent and Trademark Office (USPTO) followed by the issuance of the '302 patent on July 26, 2011 and the '514 patent on June 26, 2012. These three patents cover key aspects of products used to passively disinfect and protect intravenous access ports.
Catheter Connections moved for summary judgment, asking the Court to find that its DualCap Solo and Dual Cap Solo IV-Pole Strip products do not infringe any of Ivera's patents. The Court declined, denying Catheter Connections' motion in its entirety. "We are pleased with the Court's decision, which we believe reflects the strength of our disinfecting cap patent portfolio," said Bob Rogers, CEO of Ivera Medical. "Catheter Connections has taken many liberties with our technology and product development, and this lawsuit is just one of our actions against them. We look forward to taking this issue to trial. Ivera has spent significant resources on its patent portfolio and we will continue to vigorously defend our intellectual property."
About Ivera Medical
Ivera Medical Corporation, a certified Minority Business Enterprise (MBE), is focused on the design, development, manufacture, marketing and sale of products that help healthcare providers reduce facility-acquired patient infections. Curos, manufactured in Carlsbad, CA, is the first disinfecting cap to be marketed in the U.S. and has received FDA's 510(k) market clearance. For more information about Curos and Ivera Medical, visit the website at www.curos.com
Vice President, Business Development
Ivera Medical Corp.
Aug. 30, 2016 05:45 AM EDT Reads: 2,446
Aug. 30, 2016 03:45 AM EDT Reads: 470
Aug. 30, 2016 02:30 AM EDT Reads: 1,856
Aug. 30, 2016 02:00 AM EDT Reads: 2,239
Aug. 30, 2016 01:30 AM EDT Reads: 3,051
Aug. 30, 2016 01:15 AM EDT Reads: 2,345
Aug. 30, 2016 01:00 AM EDT Reads: 1,939
Aug. 30, 2016 12:00 AM EDT Reads: 1,668
Aug. 29, 2016 10:00 PM EDT Reads: 2,491
Aug. 29, 2016 08:30 PM EDT Reads: 2,450
Aug. 29, 2016 08:15 PM EDT Reads: 1,877
Aug. 29, 2016 08:00 PM EDT Reads: 926
Aug. 29, 2016 07:00 PM EDT Reads: 1,985
Aug. 29, 2016 06:45 PM EDT Reads: 854
Almost two-thirds of companies either have or soon will have IoT as the backbone of their business in 2016. However, IoT is far more complex than most firms expected. How can you not get trapped in the pitfalls? In his session at @ThingsExpo, Tony Shan, a renowned visionary and thought leader, will introduce a holistic method of IoTification, which is the process of IoTifying the existing technology and business models to adopt and leverage IoT. He will drill down to the components in this fra...
Aug. 29, 2016 06:15 PM EDT Reads: 357